MedPath

湖北绿金子药业有限责任公司

Ownership
-
Established
2004-09-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

72

NMPA:72

Drug Approvals

痛风舒片

Approval Number
国药准字Z20090687
Approval Date
Nov 16, 2023
NMPA

Pepsin

Product Name
胃蛋白酶
Approval Number
国药准字H42022212
Approval Date
Jun 16, 2021
NMPA

Pancreatin

Product Name
胰酶
Approval Number
国药准字H42022479
Approval Date
Jun 16, 2021
NMPA

Chondroitin Sulfate Sodium

Product Name
硫酸软骨素钠
Approval Number
国药准字H42022477
Approval Date
Jun 16, 2021
NMPA

Gastric Mucin

Product Name
胃膜素
Approval Number
国药准字H42022478
Approval Date
Jun 16, 2021
NMPA

Vitacoenzyme

Product Name
维酶素
Approval Number
国药准字H42022636
Approval Date
Jun 16, 2021
NMPA

Chondroitin Sulfate Sodium Tablets

Product Name
硫酸软骨素钠片
Approval Number
国药准字H20043556
Approval Date
Jul 20, 2020
NMPA

Chondroitin Sulfate Sodium Tablets

Product Name
硫酸软骨素钠片
Approval Number
国药准字H42020738
Approval Date
Jul 20, 2020
NMPA

Compound Hepar Extract Tablets

Product Name
复方肝水解物片
Approval Number
国药准字H42022800
Approval Date
May 19, 2020
NMPA

金银花露

Approval Number
国药准字Z42020850
Approval Date
May 19, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.